FAQs Below are the most common questions patients ask about the PharmaZee GLP-1 program, along with detailed answers to help you make an informed decision before starting

Semaglutide is a GLP-1 receptor agonist licensed in the UK for type 2 diabetes mellitus and weight management Standard blood panels do not detect semaglutide levels as these are not routinely measured in UK clinical practice Ozempic typically reduces HbA1c by 1.01.5% and improves metabolic parameters including lipid profiles and liver enzymes Regular monitoring includes HbA1c every 36 months, annual renal and liver function tests, and assessment for gastrointestinal side effects Patients must inform all healthcare providers about Ozempic use, particularly before surgical procedures due to delayed gastric emptying Table of Contents Understanding Ozempic and Routine Blood Tests Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus and, at higher doses under the brand name Wegovy, for weight management in specific patient groups

Concurrent colonoscopy was found to reduce GRC risk among GLP-1 RA users (OR 0.27
The cost of Mounjaro is significant, with monthly expenses ranging from $1,000 to $1,200, depending on the pharmacy
The key is understanding what your body may be trying to tell you